Kazia Therapeutics (which formerly traded as Novogen Limited) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.

SITE BY SPATIAL DESIGN